Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response is a research paper published in Leukemia (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | National Institutes of Health (NIH)
Grant: KL2TR001879
U.S. Department of Health & Human Services | National Institutes of Health (NIH)
Grant: R00CA248460
U.S. Department of Health & Human Services | National Institutes of Health (NIH)
Grant: R35CA197731
NCI NIH HHS
Grant: K08 CA230190
BLRD VA
Grant: I01 BX000918
NIEHS NIH HHS
Grant: P30 ES013508
NCI NIH HHS
Grant: R35 CA220483
NCI NIH HHS
Grant: U54 CA283759
American Society of Clinical Oncology (ASCO)
Grant: YIA
NCI NIH HHS
Grant: P30 CA016056
U.S. Department of Health & Human Services | National Institutes of Health (NIH)
Grant: T32HL0439
U.S. Department of Health & Human Services | National Institutes of Health (NIH)
Grant: P30CA16056
NCI NIH HHS
Grant: P30 CA062203
U.S. Department of Health & Human Services | National Institutes of Health (NIH)
Grant: P30CA046934
American Society of Hematology (ASH)
Grant: RTAF
NHLBI NIH HHS
Grant: T32 HL007439
U.S. Department of Defense (United States Department of Defense)
Grant: W81XWH-20-1-0867
National Institutes of Health
Grant: 5R35CA197731-03
Targeting Mutant KRAS for Cancer Therapy
National Institutes of Health
Grant: 5KL2TR001879-04
Institutional Clinical and Translational Science Award
National Institutes of Health
Grant: 7K08CA230190-02
Improving targeted therapy in FLT3-mutated AML
National Institutes of Health
Grant: 3P30CA046934-20S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5I01BX000918-03
Therapeutic targeting of Src kinase signal transduction pathways in AML
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 4R00CA248460-03
Interrogating oncogene-dependency and mutation order in FLT3 mutant AML
National Institutes of Health
Grant: 5R35CA220483-02
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
National Institutes of Health
Grant: 5P30ES013508-04
CORE--Endocrine and Reproduction Disruption
Fields of Study
MeSH Terms
Keywords